26.04.2022 12:29:50
|
DGAP-AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
DGAP Preliminary announcement financial reports: PharmaSGP Holding SE
/ Preliminary announcement on the disclosure of financial statements
PharmaSGP Holding SE hereby announces that the following financial reports shall be disclosed: Report Type: Annual financial report Language: German Date of disclosure: April 28, 2022 Address: https://ir.pharmasgp.com/#Finanzberichte Language: English Date of disclosure: April 28, 2022 Address: https://ir.pharmasgp.com/en/#FinancialReports Report Type: Annual financial report of the group Language: German Date of disclosure: April 28, 2022 Address: https://ir.pharmasgp.com/#Finanzberichte Language: English Date of disclosure: April 28, 2022 Address: https://ir.pharmasgp.com/en/#FinancialReports
26.04.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | PharmaSGP Holding SE |
Lochhamer Schlag 21 | |
82166 Gräfelfing | |
Germany | |
Internet: | https://pharmasgp.com |
End of News | DGAP News Service |
|
1335603 26.04.2022
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu PharmaSGPmehr Nachrichten
27.11.24 |
Ausblick: PharmaSGP legt Quartalsergebnis vor (finanzen.net) | |
25.11.24 |
EQS-DD: PharmaSGP Holding SE: FUTRUE GmbH, Kauf (EQS Group) | |
25.11.24 |
EQS-DD: PharmaSGP Holding SE: FUTRUE GmbH, buy (EQS Group) | |
14.11.24 |
EQS-News: PharmaSGP with strong revenues growth in 9M 2024 – revenues forecast for FY 2024 raised (EQS Group) | |
14.11.24 |
EQS-News: PharmaSGP mit kräftigem Umsatzwachstum in 9M 2024 – Erhöhung der Umsatzprognose für FY 2024 (EQS Group) | |
05.11.24 |
EQS-News: CEO-Wechsel bei der PharmaSGP Holding SE: Peter Gerckens folgt zum 01. Januar 2025 auf Natalie Weigand (EQS Group) | |
05.11.24 |
EQS-News: CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as of January 1, 2025 (EQS Group) | |
05.11.24 |
EQS-Adhoc: PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer (EQS Group) |